Repatenting for Profits and the High Costs of Breathing

Posted by & filed under Accounting Principles, Cost Accounting, Financial Accounting, Managerial Accounting.

Unlike other countries, where the government directly or indirectly sets an allowed national wholesale price for each drug, the United States leaves prices to market competition among pharmaceutical companies, including generic drug makers. This has resulted in a vicious cycle of repatenting old drugs that use to cost pennies with new delivery systems and processes… Read more »